An audit of thromboprophylaxis for patients with myeloma on the immunomodulatory therapies: thalidomide, lenalidomide or pomalidomide

被引：0
|
作者：
Melly, M. [1 ]
Al-Talib, M. [1 ]
机构：
[1] North Bristol NHS Trust, Bristol, Avon, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷
关键词：
immunomodulatory drugs; lenalidomide; myeloma; pomalidomide; thalidomide; thromboprophylaxis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH18-EP-0
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [21] Thromboprophylaxis in patients with myeloma on 'imid' therapies - an audit of outcomes following introduction of direct oral anticoagulants.
    Jamil, Fatima
    Langridge, Alexander
    Acres, Meghan
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 159 - 159
  • [22] Thalidomide and lenalidomide in the treatment of multiple myeloma
    Kumar, Shaji
    Rajkumar, S. Vincent
    [J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (11) : 1612 - 1622
  • [23] Identifying Myeloma Patients at Risk of Lenalidomide or Pomalidomide Resistance at Relapse: A New Opportunity
    Singh, Suvir
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (02) : 180 - 181
  • [24] POMALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PREVIOUSLY TREATED WITH LENALIDOMIDE
    Gomez, Hernando Marta
    Gironella, Merce
    Abella, Eugenia
    Cabezudo, Elena
    Motllo, Cristina
    Garcia, Antoni
    Sarra, Josep
    Mostacedo, Silvia
    Granell, Miquel
    Rosinol, Laura
    [J]. HAEMATOLOGICA, 2020, 105 : 13 - 14
  • [25] Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
    Paludo, Jonas
    Mikhael, Joseph R.
    LaPlant, Betsy R.
    Halvorson, Alese E.
    Kumar, Shaji
    Gertz, Morie A.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dispenzieri, Angela
    Lust, John A.
    Kapoor, Prashant
    Leung, Nelson
    Russell, Stephen J.
    Dingli, David
    Go, Ronald S.
    Lin, Yi
    Gonsalves, Wilson I.
    Fonseca, Rafael
    Bergsagel, P. Leif
    Roy, Vivek
    Sher, Taimur
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    Stewart, A. Keith
    Reeder, Craig B.
    Richardson, Paul G.
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    [J]. BLOOD, 2017, 130 (10) : 1198 - 1204
  • [26] Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
    Carrier, M.
    Le Gal, G.
    Tay, J.
    Wu, C.
    Lee, A. Y.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (04) : 653 - 663
  • [27] Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide
    Iino, Masaki
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (02) : 223 - 224
  • [28] Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide
    Masaki Iino
    [J]. International Journal of Hematology, 2012, 95 : 223 - 224
  • [29] Poor adherence to required pregnancy tests in lenalidomide, pomalidomide and thalidomide users
    [J]. Reactions Weekly, 2024, 2009 (1) : 9 - 9
  • [30] Apixaban Is Safe and Effective Thromboprophylaxis in Myeloma Patients Treated with Immunomodulatory Therapy
    Storrar, Neill
    Mathur, Abhinav
    Johnson, Peter
    Roddie, Huw
    [J]. BLOOD, 2017, 130
12345